Stockreport

IceCure Submits FDA Regulatory Filing for New XSense™ Cryoablation System with Cryoprobes [Yahoo! Finance]

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF CAESAREA, Israel April 2, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive [Read more]